1H and 31P MR Spectroscopy to Assess Muscle Mitochondrial Dysfunction in Long COVID

Lucy E M Finnigan1, Mark Philip Cassar1, Mehrsa Jafarpour1

  • 1From the Oxford Centre for Clinical Magnetic Resonance Research (OCMR), Division of Cardiovascular Medicine, Radcliffe Department of Medicine, University of Oxford, John Radcliffe Hospital, Headley Way, Oxford OX3 9DU, UK (L.E.M.F., M.P.C., M.J., A.S., Z.A., S.N., D.J.T., B.R., L.V.); Oncology and Haematology Centre, Churchill Hospital, Oxford, UK (A.S.); Axcella Therapeutics, Cambridge, Mass (K.A.); and Institute of Measurement Science, Slovak Academy of Sciences, Bratislava, Slovakia (L.V.).

Radiology
|December 24, 2024
PubMed
Summary

Post-COVID-19 condition (PCC) patients exhibit altered mitochondrial function, indicated by changes in phosphocreatine recovery and oxidative flux, suggesting potential mitochondrial dysfunction. However, these MR spectroscopy findings did not correlate with fatigue severity in PCC individuals.